Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain
Pain after surgery causes significant suffering. Opioid analgesics cause severe side effects and accidental death. Therefore, there is an urgent need to develop non-opioid therapies for managing post-surgical pain. Local application of Clarix Flo (FLO), a human amniotic membrane (AM) product, attenu...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
eLife Sciences Publications Ltd
2024-12-01
|
| Series: | eLife |
| Subjects: | |
| Online Access: | https://elifesciences.org/articles/101269 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850061301041070080 |
|---|---|
| author | Chi Zhang Qian Huang Neil C Ford Nathachit Limjunyawong Qing Lin Fei Yang Xiang Cui Ankit Uniyal Jing Liu Megha Mahabole Hua He Xuewei Wang Irina Duff Yiru Wang Jieru Wan Guangwu Zhu Srinivasa N Raja Hongpeng Jia Dazhi Yang Xinzhong Dong Xu Cao Scheffer C Tseng Shaoqiu He Yun Guan |
| author_facet | Chi Zhang Qian Huang Neil C Ford Nathachit Limjunyawong Qing Lin Fei Yang Xiang Cui Ankit Uniyal Jing Liu Megha Mahabole Hua He Xuewei Wang Irina Duff Yiru Wang Jieru Wan Guangwu Zhu Srinivasa N Raja Hongpeng Jia Dazhi Yang Xinzhong Dong Xu Cao Scheffer C Tseng Shaoqiu He Yun Guan |
| author_sort | Chi Zhang |
| collection | DOAJ |
| description | Pain after surgery causes significant suffering. Opioid analgesics cause severe side effects and accidental death. Therefore, there is an urgent need to develop non-opioid therapies for managing post-surgical pain. Local application of Clarix Flo (FLO), a human amniotic membrane (AM) product, attenuated established post-surgical pain hypersensitivity without exhibiting known side effects of opioid use in mice. This effect was achieved through direct inhibition of nociceptive dorsal root ganglion (DRG) neurons via CD44-dependent pathways. We further purified the major matrix component, the heavy chain-hyaluronic acid/pentraxin 3 (HC-HA/PTX3) from human AM that has greater purity and water solubility than FLO. HC-HA/PTX3 replicated FLO-induced neuronal and pain inhibition. Mechanistically, HC-HA/PTX3-induced cytoskeleton rearrangements to inhibit sodium current and high-voltage activated calcium current on nociceptive DRG neurons, suggesting it is a key bioactive component mediating pain relief. Collectively, our findings highlight the potential of naturally derived biologics from human birth tissues as an effective non-opioid treatment for post-surgical pain. Moreover, we unravel the underlying neuronal mechanisms of pain inhibition induced by FLO and HC-HA/PTX3. |
| format | Article |
| id | doaj-art-55e265c0aaeb41ad867c2758618dc1f9 |
| institution | DOAJ |
| issn | 2050-084X |
| language | English |
| publishDate | 2024-12-01 |
| publisher | eLife Sciences Publications Ltd |
| record_format | Article |
| series | eLife |
| spelling | doaj-art-55e265c0aaeb41ad867c2758618dc1f92025-08-20T02:50:17ZengeLife Sciences Publications LtdeLife2050-084X2024-12-011310.7554/eLife.101269Human birth tissue products as a non-opioid medicine to inhibit post-surgical painChi Zhang0Qian Huang1Neil C Ford2Nathachit Limjunyawong3Qing Lin4Fei Yang5Xiang Cui6Ankit Uniyal7Jing Liu8Megha Mahabole9Hua He10Xuewei Wang11Irina Duff12Yiru Wang13Jieru Wan14Guangwu Zhu15Srinivasa N Raja16Hongpeng Jia17Dazhi Yang18Xinzhong Dong19https://orcid.org/0000-0002-9750-7718Xu Cao20https://orcid.org/0000-0001-8614-6059Scheffer C Tseng21Shaoqiu He22Yun Guan23https://orcid.org/0000-0003-1321-6655Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesThe Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesBioTissue, Inc, Miami, United StatesBioTissue, Inc, Miami, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United States; Department of Orthopaedic Surgery, Johns Hopkins University, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Surgery, Johns Hopkins University, School of Medicine, Baltimore, United StatesAcrogenic Technologies Inc, Rockville, United StatesThe Solomon H. Snyder Department of Neuroscience, Center for Sensory Biology, Johns Hopkins University, School of Medicine, Baltimore, United States; Howard Hughes Medical Institute, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Orthopaedic Surgery, Johns Hopkins University, Baltimore, United StatesBioTissue, Inc, Miami, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United StatesDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United States; Department of Neurological Surgery, Johns Hopkins University, School of Medicine, Baltimore, United StatesPain after surgery causes significant suffering. Opioid analgesics cause severe side effects and accidental death. Therefore, there is an urgent need to develop non-opioid therapies for managing post-surgical pain. Local application of Clarix Flo (FLO), a human amniotic membrane (AM) product, attenuated established post-surgical pain hypersensitivity without exhibiting known side effects of opioid use in mice. This effect was achieved through direct inhibition of nociceptive dorsal root ganglion (DRG) neurons via CD44-dependent pathways. We further purified the major matrix component, the heavy chain-hyaluronic acid/pentraxin 3 (HC-HA/PTX3) from human AM that has greater purity and water solubility than FLO. HC-HA/PTX3 replicated FLO-induced neuronal and pain inhibition. Mechanistically, HC-HA/PTX3-induced cytoskeleton rearrangements to inhibit sodium current and high-voltage activated calcium current on nociceptive DRG neurons, suggesting it is a key bioactive component mediating pain relief. Collectively, our findings highlight the potential of naturally derived biologics from human birth tissues as an effective non-opioid treatment for post-surgical pain. Moreover, we unravel the underlying neuronal mechanisms of pain inhibition induced by FLO and HC-HA/PTX3.https://elifesciences.org/articles/101269painhuman birth tissuessensory neuronsCD44cytoskeleton rearrangement |
| spellingShingle | Chi Zhang Qian Huang Neil C Ford Nathachit Limjunyawong Qing Lin Fei Yang Xiang Cui Ankit Uniyal Jing Liu Megha Mahabole Hua He Xuewei Wang Irina Duff Yiru Wang Jieru Wan Guangwu Zhu Srinivasa N Raja Hongpeng Jia Dazhi Yang Xinzhong Dong Xu Cao Scheffer C Tseng Shaoqiu He Yun Guan Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain eLife pain human birth tissues sensory neurons CD44 cytoskeleton rearrangement |
| title | Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain |
| title_full | Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain |
| title_fullStr | Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain |
| title_full_unstemmed | Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain |
| title_short | Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain |
| title_sort | human birth tissue products as a non opioid medicine to inhibit post surgical pain |
| topic | pain human birth tissues sensory neurons CD44 cytoskeleton rearrangement |
| url | https://elifesciences.org/articles/101269 |
| work_keys_str_mv | AT chizhang humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT qianhuang humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT neilcford humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT nathachitlimjunyawong humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT qinglin humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT feiyang humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT xiangcui humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT ankituniyal humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT jingliu humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT meghamahabole humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT huahe humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT xueweiwang humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT irinaduff humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT yiruwang humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT jieruwan humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT guangwuzhu humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT srinivasanraja humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT hongpengjia humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT dazhiyang humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT xinzhongdong humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT xucao humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT schefferctseng humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT shaoqiuhe humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain AT yunguan humanbirthtissueproductsasanonopioidmedicinetoinhibitpostsurgicalpain |